TR200102287T2 - Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı - Google Patents

Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı

Info

Publication number
TR200102287T2
TR200102287T2 TR2001/02287T TR200102287T TR200102287T2 TR 200102287 T2 TR200102287 T2 TR 200102287T2 TR 2001/02287 T TR2001/02287 T TR 2001/02287T TR 200102287 T TR200102287 T TR 200102287T TR 200102287 T2 TR200102287 T2 TR 200102287T2
Authority
TR
Turkey
Prior art keywords
cancers
bis
triazoles
drug
manufacture
Prior art date
Application number
TR2001/02287T
Other languages
English (en)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200102287T2 publication Critical patent/TR200102287T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus, memelilerde, özellikle insan ve sicak kanli hayvanlarda kanserlerin ve tümörlerin gelismesini engelleyen bir farmasötik terkiptir. Bu terkip, bir 1,3-bis-triazolil-2-propanol türevi ihtiva eder.
TR2001/02287T 1995-06-07 1996-05-22 Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı TR200102287T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/473,818 US5665751A (en) 1995-06-07 1995-06-07 Pharmaceutical composition for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
TR200102287T2 true TR200102287T2 (tr) 2002-06-21

Family

ID=23881116

Family Applications (2)

Application Number Title Priority Date Filing Date
TR97/01535T TR199701535T1 (tr) 1995-06-07 1996-05-22 Bis-1,2,4- triazolleri, kanserlerin tedavisi için bir ilaç üretilmesinde kullanimi.
TR2001/02287T TR200102287T2 (tr) 1995-06-07 1996-05-22 Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR97/01535T TR199701535T1 (tr) 1995-06-07 1996-05-22 Bis-1,2,4- triazolleri, kanserlerin tedavisi için bir ilaç üretilmesinde kullanimi.

Country Status (20)

Country Link
US (3) US5665751A (tr)
EP (1) EP0831815A1 (tr)
JP (1) JPH11506733A (tr)
KR (1) KR19990022618A (tr)
CN (1) CN1259867A (tr)
AR (1) AR003430A1 (tr)
AU (1) AU717201B2 (tr)
BR (1) BR9609093A (tr)
CA (1) CA2223803A1 (tr)
CZ (1) CZ391897A3 (tr)
HU (1) HUP9802629A3 (tr)
IL (1) IL118426A (tr)
NO (1) NO975661L (tr)
NZ (1) NZ308393A (tr)
PL (1) PL324078A1 (tr)
SK (1) SK168797A3 (tr)
TR (2) TR199701535T1 (tr)
TW (1) TW466113B (tr)
WO (1) WO1996040120A1 (tr)
ZA (1) ZA964377B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ283135A (en) * 1994-03-21 2004-12-24 Thomsen John Brown Gel formulation for treatment of skin diseases and disinfection/disinfestation of the skin
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
PL324904A1 (en) * 1995-08-04 1998-06-22 Procter & Gamble Application of fluconazole in carcinoma development inhibition
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
CN100334084C (zh) * 2005-04-26 2007-08-29 武汉大学 联三唑化合物及其制备方法和用途
CN100451007C (zh) * 2006-10-12 2009-01-14 杭州宇龙化工有限公司 含芳醚双三氮唑类化合物及其用途
WO2008079976A2 (en) 2006-12-21 2008-07-03 Centocor, Inc. Dimeric high affinity egfr constructs and uses thereof
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
US8536113B2 (en) 2006-12-21 2013-09-17 Janssen Biotech, Inc. EGFR binding peptides and uses thereof
KR100980328B1 (ko) * 2007-12-14 2010-09-06 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는트리아졸릴-티오-에타논 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 암 예방 및 치료용조성물
CN102321036A (zh) * 2011-07-13 2012-01-18 王健祥 一种氟康唑可溶性盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) * 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) * 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration

Also Published As

Publication number Publication date
NZ308393A (en) 2001-04-27
NO975661D0 (no) 1997-12-05
NO975661L (no) 1998-02-09
IL118426A0 (en) 1996-09-12
JPH11506733A (ja) 1999-06-15
AU717201B2 (en) 2000-03-23
CZ391897A3 (cs) 1998-05-13
PL324078A1 (en) 1998-05-11
HUP9802629A3 (en) 2000-01-28
US5840742A (en) 1998-11-24
USRE37003E (en) 2000-12-26
ZA964377B (en) 1997-02-17
HUP9802629A2 (hu) 1999-04-28
AR003430A1 (es) 1998-08-05
EP0831815A1 (en) 1998-04-01
BR9609093A (pt) 1999-06-29
CN1259867A (zh) 2000-07-12
WO1996040120A1 (en) 1996-12-19
IL118426A (en) 2001-03-19
KR19990022618A (ko) 1999-03-25
CA2223803A1 (en) 1996-12-19
TW466113B (en) 2001-12-01
AU5802196A (en) 1996-12-30
SK168797A3 (en) 1998-12-02
TR199701535T1 (tr) 1998-03-21
US5665751A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
TR200102287T2 (tr) Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı
TR199701534T1 (tr) 1,2,4-triazol türevlerinin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanimi.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR200001544T2 (tr) Yeni bileşikler.
CY1113967T1 (el) Μη-υδατικη φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση περιλαμβανουσα βιταμινη d, κορτικοστεροειδες και ενα συστατικο διαλυτη
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
TR199800270T1 (tr) Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.
TR199902071T2 (tr) Heterosiklik bilesikler ve bunlarin -amilioid peptidinin inhibisyonunda kullanimi
TR199802423T2 (tr) Konsantre antikor terkibi.
CY1105144T1 (el) Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες
TR200100918T2 (tr) Aril ve heteroaril sübstitüentli üreler kullanılarak RAF kinazın inhibe edilmesi
TR199903331T2 (tr) Farnesil protein transferas engelleyicileri.
BG101284A (en) Compounds and methods for cancer treatment
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
NO996253L (no) Diagnostiske midler og legemidler for maligne tumorer
TR199701150T1 (tr) Memeli canlilarda virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari, N-klorofeniltiokarbamatlari ve N-fosfonoglisin türevlerini içeren bir farmasötik bilesim.
TR199901904T2 (tr) 3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi.
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
AR024847A1 (es) 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento.
NO974696D0 (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
TR199800245T2 (tr) 1H-1,2,4-triazol türevlerinin, kanserlerin ilerlemesini önlemede kullanimi.
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
PT841912E (pt) 2-aminocarbonil-1,2-bis(metilsulfonil)-1-(substituido)-hidrazinas antitumor